Inactive Instrument
Mazorro Resources Inc. Stock Deutsche Boerse AG
Stocks
CA5788691098
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| Market Cap | 9.22M 7.97M 7.48M 6.81M 12.8M 882M 12.99M 87.7M 34.33M 442M 34.63M 33.88M 1.47B | P/E 2020 |
-1.43x | P/E 2021 | -1.33x |
|---|---|---|---|---|---|
| Enterprise Value | 7.45M 6.43M 6.04M 5.5M 10.34M 712M 10.49M 70.83M 27.73M 357M 27.97M 27.36M 1.19B | EV / Sales 2020 |
-
| EV / Sales 2021 | - |
| Free-Float |
100% | Yield 2020 * |
-
| Yield 2021 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Derek Theriault
PRN | Corporate Officer/Principal | - | - |
Steeve Néron
COO | Chief Operating Officer | - | 2019-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
H. Norton
CHM | Chairman | 65 | 2021-05-27 |
| Director/Board Member | 70 | 2020-09-16 | |
Catherine Auld
BRD | Director/Board Member | - | 2021-05-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | -1.89% | -11.01% | -6.99% | 13.24B | |
| -0.16% | -2.40% | -32.52% | -57.64% | 4.98B | |
| -0.81% | -3.56% | +2.32% | -3.16% | 4.91B | |
| +0.29% | +0.12% | +7.12% | -28.17% | 4.2B | |
| -0.03% | -2.74% | -18.37% | +0.58% | 3.59B | |
| +0.20% | -2.29% | -5.07% | +13.86% | 3.4B | |
| -1.06% | -6.37% | -8.56% | -9.04% | 3.35B | |
| +1.19% | +0.94% | -12.60% | -15.53% | 2.49B | |
| 0.00% | +10.60% | +3.45% | -10.45% | 1.81B | |
| Average | -0.09% | -0.25% | -8.36% | -12.95% | 4.66B | |
| Weighted average by Cap. | -0.23% | -1.31% | -9.61% | -13.15% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.48M -22.87M -21.46M -19.55M -36.73M -2.53B -37.28M -252M -98.54M -1.27B -99.4M -97.24M -4.22B | -52.18M -45.06M -42.29M -38.53M -72.39M -4.99B -73.47M -496M -194M -2.5B -196M -192M -8.32B |
| Net Debt | -501K -432K -406K -370K -695K -47.85M -705K -4.76M -1.86M -23.98M -1.88M -1.84M -79.8M | -1.77M -1.53M -1.44M -1.31M -2.46M -170M -2.5M -16.87M -6.6M -85M -6.66M -6.52M -283M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
